By Karen Roman Toronto-based biotech company Radiant Biotherapeutics announced the designation of Deborah Geraghty, Ph.D., as President and Chief Executive Officer. The company also appointed Stefan Larson, Ph.D., as Chair of the Board of Directors, and Ingmar Bruns, M.D., Ph.D.,...

By Karen Roman Ascentage Pharma Group International (Nasdaq: AAPG) said it designated Veet Misra, Ph.D., as Chief Financial Officer, and Eric Huang as Senior Vice President of Global Corporate Development and Finance. Dr. Misra has more than 20 years of...

By Karen Roman Oncology-focused biotech company SkylineDx said an independent study shows that Merlin CP-GEP, the company’s test for treatment decisions in early-stage melanoma, correctly categorizes patients with skin melanoma for sentinel lymph node biopsy (SLNB). Merlin acts as a...

By Karen Roman Nano-X Imaging Ltd. (Nasdaq: NNOX) said it started a clinical and educational collaboration with Keiser University to give students access to 3D imaging system through the use of Nanox.ARC. The system will be deployed at the university’s...

By Daniella Parra A new study published in the British Journal of Haematology confirms that the SKY92 gene expression profiling test significantly enhances risk stratification in multiple myeloma patients, outperforming traditional clinical markers, SkylineDx said. Risk stratification by SKY92 showed...

By Karen Roman Biotech company Beacon Therapeutics Holdings Ltd announced the designation of Dr. Daniel Chung as its new Chief Medical Officer. Dr. Chung has three decades of experience in clinical ophthalmology and academic research, and he formerly served as...

By Karen Roman Nano-X Imaging Ltd. (Nasdaq: NNOX) said its AI bone solution HealthOST has received CE mark certification which enables its commercialization across Europe. HealthOST examines CT scans to assess vertebral height loss and bone mineral density and helps...

By Daniella Parra Jeito Capital said it led a $65 million Series A funding round in ReproNovo, a biotech company focused on reproductive medicine and women’s health/. ReproNovo is addressing male and female infertility and uterine health advancing in RPN-001, an...

By Daniella Parra Promontory Therapeutics said its Phase 2 meeting with the FDA cleared the way to launch a Phase 3 registrational trial of PT-112 monotherapy for metastatic castration-resistant prostate cancer. The company is a small, NYC-based biotech that, to...

By Karen Roman ReAlta Life Sciences said it presented new clinical data from its Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AE-COPD) program at the American Thoracic Society 2025 International Conference, taking place on May 18-21, in San Francisco. The...